TABLE 1.
Characteristics | n (%) |
---|---|
Age, years | |
Median age (range) | 62 (39–75) |
<60 | 42 (37.8) |
≥60 | 69 (62.2) |
Sex | |
Male | 69 (62.2) |
Female | 42 (37.8) |
Smoking status | |
Never smoker | 39 (35.1) |
Smoker | 72 (64.9) |
Histological type | |
AD | 81 (73.0) |
Non‐AD | 30 (27.0) |
p‐TNM stage | |
Stage II | 35 (31.5) |
Stage IIIA | 76 (68.5) |
Chemotherapeutic regimen | |
CBDCA based | 28 (25.2) |
CDDP based | 83 (74.8) |
Number of treatment cycle | |
1–2 | 15 (13.5) |
3–4 | 96 (86.5) |
Survival status | |
Alive | 60 (54.1) |
Lung cancer‐related death | 40 (36.0) |
Other causes of death | 5 (4.5) |
Unknown | 6 (5.4) |
Abbreviations: AD, adenocarcinoma; CBDCA, carboplatin; CDDP, cisplatin; p‐TNM, pathological TNM eighth edition.